The Nutshell

» cancer, cell & molecular biology and NIH

Daily News Roundup

Most Recent

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

The Oracle cofounder’s gift will fund a new institute at the University of Southern California.

0 Comments

image: Tasmanian Devil Antibodies Fight Cancer

Tasmanian Devil Antibodies Fight Cancer

By | May 9, 2016

The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.

0 Comments

image: Embryo Watch

Embryo Watch

By | May 5, 2016

A new culture system allows researchers to track the development of human embryos in vitro for nearly two weeks.

1 Comment

image: Observing the Nuclear Pore

Observing the Nuclear Pore

By | May 2, 2016

Scientists visualize nuclear pore complexes for the first time, using high-speed atomic force microscopy.

1 Comment

image: Speaking of Cancer Research

Speaking of Cancer Research

By , , and | April 20, 2016

A selection of notable quotes from the annual American Association for Cancer Research meeting

0 Comments

image: Two NIH Labs Cease Reagent Production

Two NIH Labs Cease Reagent Production

By | April 20, 2016

Contamination concerns at cell therapy and radioactive tracer facilities spur production shutdowns.

0 Comments

image: AACR Q&A: Angelika Amon

AACR Q&A: Angelika Amon

By | April 19, 2016

The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.

0 Comments

image: Running from Cancer?

Running from Cancer?

By | April 18, 2016

At the American Association for Cancer Research annual meeting, researchers review the evidence that exercise has antitumor benefits.

0 Comments

image: AACR Q&A: Elaine Mardis

AACR Q&A: Elaine Mardis

By | April 18, 2016

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

0 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. A History of Screening for Natural Products to Fight Cancer
  4. March for Science: Dispatches from Washington, DC
AAAS